Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
biotech IPO
Biotech
Vaxxinity retreats from 'abusive relationship' of public market
Vaxxinity is choosing transparency about the “abusive relationship” that defined the immunotherapy company’s three-year stint as a public company.
Annalee Armstrong
May 15, 2024 9:59am
CG sets new bar in bladder cancer, months after huge IPO
May 3, 2024 11:23am
'Next wave of IPOs' will arrive in summer, predicts VC partner
May 3, 2024 10:49am
Contineum lowers expectations for $110M IPO
Apr 5, 2024 7:00am
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Apr 3, 2024 9:00am
Boundless boldly goes public with $100M IPO
Mar 28, 2024 7:10am